|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$320||Benefits minus costs||($1,970)|
|Participants||$4||Benefit to cost ratio||($0.17)|
|Others||$72||Chance the program will produce|
|Indirect||($682)||benefits greater than the costs||41 %|
|Net program cost||($1,685)|
|Benefits minus cost||($1,970)|
|Detailed Monetary Benefit Estimates Per Participant|
|Benefits from changes to:1||Benefits to:|
|Health care associated with psychiatric hospitalization||$320||$4||$72||$160||$557|
|Adjustment for deadweight cost of program||$0||$0||$0||($842)||($842)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$1,602||2014||Present value of net program costs (in 2018 dollars)||($1,685)|
|Comparison costs||$0||2014||Cost range (+ or -)||10 %|
|Estimated Cumulative Net Benefits Over Time (Non-Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in non-discounted dollars to simplify the “break-even” point from a budgeting perspective. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
|Emergency department visits^^||49||1||44||0.228||0.254||50||n/a||n/a||n/a||0.228||0.369|
Fardig, R., Lewander, T., Melin, L., Folke, F., & Fredriksson, A. (2011). A randomized controlled trial of the illness management and recovery program for persons with schizophrenia. Psychiatric Services, 62(6), 606-612.
Levitt, A., Mueser, K., DeGenova, J., Lorenzo, J., Bradford-Watt, D., Barbosa, A., . . . & Chernick, M. (2009). Randomized controlled trial of illness management and recovery in multiple-unit supportive housing. Psychiatric Services, 60(12), 1629-1636.
Salyers, M.P., McGuire, A.B., Rollins, A.L., Bond, G.R., Mueser, K.T., & Macy, V.R. (2010). Integrating assertive community treatment and illness management and recovery for consumers with severe mental illness. Community Mental Health Journal, 46(4), 319-329.
Salyers, M.P., McGuire, A B., Kukla, M., Fukui, S., Lysaker, P.H., & Mueser, K.T. (2014). A randomized controlled trial of illness management and recovery with an active control group. Psychiatric Services, 65(8), 1005-1011.